UKSPA Directory 2017 2017-18 - Page 126

126 Wales | Full Member Institute of Life Science L ocati on Swansea University Singleton Park Swansea SA2 8PP C ontact detai l s Nia Morse Project Manager Enterprise & Innovation Team T: 01792 513718 E: ilsinnovation@swansea.ac.uk www.ils.swansea.ac.uk @ILS_EI UKSPA Directory 2017 The Institute of Life Science (ILS) is Wales’ premier purpose-built medical research and business incubation facility. It is a partnership between Swansea University, Welsh Government, the NHS, ABMU Health Board, and business partners. It provides a cornerstone for the regional MediPark vision being developed as part of the ARCH (A Regional Collaboration for Health) delivered in partnership between University Health Boards, industry, academia, and Welsh Government. The vision for the ILS is to advance medical science through multi- and inter-disciplinary research and innovation for the benefit of human health, and to link those benefits to the economy by encouraging interaction with other organisations in a spirit of Open Innovation. Shaping the Future for the He alth and We alth of Wales The first phase of the ILS vision – valued at £52m – delivered a state-of-the-art building (ILS1) housing over 200 professional specialists in medical research, high-performance computing, business incubation, and technology transfer. The second phase of the vision – which received £28.8m funding – boasts a further 6,000m 2 of facilities that build capacity, expertise, and infrastructure to benefit the nation’s health and wealth. Standing adjacent to Singleton Hospital, the award-winning ILS1 & ILS2 buildings house the College of Medicine’s healthcare research, a range of fully- operational business incubation units, and the Joint Clinical Research Facility (JCRF), fully equipped with a bedded clinical trials unit and an imaging suite with cutting-edge CT and MRI scanners. ILS2 also houses the innovative Centre for NanoHealth. Other unique facilities at the ILS include the EPSRC UK National Mass Spectrometry Facility, the Haemostasis Biomedical Research Unit, the Health Informatics Research Laboratories, the NHS Wales Research Informatics Laboratories, and extensive high performance computing capabilities through HPC Wales. The business centre is home to a growing band of companies, including: Haemair Ltd: Provides support for people with lung disease or injury. Its technology takes part of the blood circulation and passes it through an “artificial lung” to oxygenate the blood and remove carbon dioxide. The aim is to provide patients with mobility, allowing them to eat, drink and talk instead of being immobile in intensive care. Haemaflow Ltd: Initially established to exploit developments spun- off from Haemair Ltd, its current priority is the development of a device to improve the safety and efficacy of transfusion blood. Supported by a grant from Innovate UK.